【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 6
List of Figures 7
Introduction 8
Global Markets Direct Report Coverage 8
Growth Hormone Deficiency Overview 9
Therapeutics Development 10
Pipeline Products for Growth Hormone Deficiency – Overview 10
Pipeline Products for Growth Hormone Deficiency – Comparative Analysis 11
Growth Hormone Deficiency – Therapeutics under Development by Companies 12
Growth Hormone Deficiency – Pipeline Products Glance 15
Late Stage Products 15
Clinical Stage Products 16
Early Stage Products 17
Unknown Stage Products 18
Growth Hormone Deficiency – Products under Development by Companies 19
Growth Hormone Deficiency – Companies Involved in Therapeutics Development 21
Aeterna Zentaris Inc. 21
Aileron Therapeutics, Inc. 22
Ascendis Pharma A/S 23
Biogenomics Limited 24
Bolder Biotechnology, Inc. 25
Braasch Biotech LLC 26
CJ CheilJedang Corp. 27
Critical Pharmaceuticals Limited 28
Delpor, Inc. 29
Emisphere Technologies, Inc. 30
Flamel Technologies S.A. 31
Genexine, Inc. 32
HanAll Biopharma Co., Ltd. 33
Hanmi Pharmaceuticals, Co. Ltd. 34
Inbiopro Solutions Pvt. Ltd. 35
LG Life Sciences, Ltd. 36
OPKO Health, Inc. 37
Pfenex Inc. 38
Prometheon Pharma, LLC 39
Teva Pharmaceutical Industries Limited 40
Versartis, Inc. 41
XL-protein GmbH 42
Growth Hormone Deficiency – Therapeutics Assessment 43
Assessment by Monotherapy Products 43
Assessment by Target 44
Assessment by Mechanism of Action 46
Assessment by Route of Administration 48
Assessment by Molecule Type 50
Drug Profiles 52
ACP-001 – Drug Profile 52
Product Description 52
Mechanism of Action 52
R&D Progress 52
albutropin – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
ALRN-5281 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
BBT-031 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
CJ-40002 – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
CP-016 – Drug Profile 59
Product Description 59
Mechanism of Action 59
R&D Progress 59
GXH-9 – Drug Profile 60
Product Description 60
Mechanism of Action 60
R&D Progress 60
HL-032 – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
HM-10560A – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
IBPB-003HH – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
macimorelin acetate – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
MOD-4023 – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Pegylated Somatropin – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
somatropin – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
somatropin – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
somatropin – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
somatropin – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
somatropin biobetter – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
somatropin biobetter – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
somatropin biosimilar – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
somatropin biosimilar – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
somatropin pegol – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
somatropin SR – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
somatropin true patch – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
SYN-20100504RU – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Vaccine for Growth Hormone Deficiencies – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
XL-020 – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
Growth Hormone Deficiency – Recent Pipeline Updates 87
Growth Hormone Deficiency – – Dormant Projects 100
Growth Hormone Deficiency – Discontinued Products 101
Growth Hormone Deficiency – Product Development Milestones 102
Featured News & Press Releases 102
Dec 29, 2014: Versartis to Hold Conference Call to Discuss VRS-317 Clinical Update From Ongoing Extension Study 102
Dec 15, 2014: Ascendis Pharma Announces Positive Six-Month Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 102
Oct 30, 2014: Versartis Schedules Conference Call to Discuss Plans for Phase 3 Trial for VRS-317 in Pediatric Growth Hormone Deficiency Patients 103
Sep 18, 2014: Prometheon’s CEO/CSO Invited to Deliver Oral Presentation at the European Society for Paediatric Endocrinology Meeting 104
Sep 16, 2014: Ascendis Pharma A/S Announces Positive Interim Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 104
Sep 11, 2014: Data Supporting Once-Weekly Dosing of hGH-CTP in Growth Hormone Deficient Pediatric Population to be Presented as a Late Breaking Presentation at the European Society of Paediatric Endocrinology Conference 105
Jun 30, 2014: Amunix Congratulates Versartis on Its Positive Phase 2a Results With VRS-317 105
Jun 27, 2014: OPKO Granted Patent from European Patent Office for Lagova 106
Jun 25, 2014: Strong Data from Lagova Phase II Clinical Study Presented during Webcast 106
Jun 23, 2014: OPKO Announces Positive Interim Six-Month Lagova (hGH-CTP) Phase 2 Data in Pediatric Growth Hormone Deficiency Disorder 107
Appendix 109
Methodology 109
Coverage 109
Secondary Research 109
Primary Research 109
Expert Panel Validation 109
Contact Us 110
Disclaimer 110
【レポート販売概要】
■ タイトル：成長ホルモン欠乏症(Growth Hormone Deficiency)の治療薬パイプライン動向（2015年上半期版）■ 英文：Growth Hormone Deficiency - Pipeline Review, H1 2015
■ 発行日：2015年1月22日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6043IDB
■ 調査対象地域：グローバル
- クラウドベースPBXの世界市場2017-2021About Cloud Based PBX A cloud-based private branch exchange (PBX) system works on cloud computing technology in which data are stored and transferred through the Internet instead of using a computer or any other hardware. Cloud technology has become popular among consumers with the introduction of programs such as MobileMe and iCloud. These are consumer-based cloud computing technologies. Technavi …
- Public Safety LTE: Contracts, Revenue, Market Share, Subscriptions and Forecasts by Vendor, Country and Spectrum Database: 2011-2015The year 2011 has seen a huge surge in demand for public safety LTE technology. This has resulted in a number of key deployments within the U.S including the City of Charlotte, Mississippi and Adams County. Recent international trials such as the Brazilian Army and Motorola Solution’s LTE trial in Brasilia have also raised awareness among the international community. Recent events such as the excl …
- 世界の低侵襲性外科手術機器市場Globally Minimally invasive / non invasive surgery and devices are widely adopted due to increase in surgeries. According to Centers for Disease Control and Prevention, there has been a solid increase in the surgeries in the US. Earlier the surgeries involved with much pain, however, with the introduction of minimally invasive/non invasive surgeries the patient experiences less pain, shorter hospi …
- 呼吸器診断の世界市場予測： 肺機能検査、イメージング検査、機械的検査、閉塞性睡眠時無呼吸（OSA）診断検査、従来式診断検査、分子診断検査The global respiratory diagnostics market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. In this report, the global market is broadly segmented by product and service, test type, disease, end user, and region. Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory …
- ジルコニウム及びハフニウムの世界市場動向2014/2015The report presents a thorough study of zirconium and hafnium, covering both global and regional markets. It aims to give a proper picture of the market, its trends, perspectives and opportunities. Comprehensive data showing zirconium and hafnium worldwide production, consumption, trade statistics and prices are provided. Each country’s market overview covers the following: zirconium and hafnium p …
- GaNデバイスの世界市場2016-2020About GaN Silicon has been the preferred choice for computing and electronic devices since its invention almost 50 years ago. However, the constant evolution of technology demands high power and ever greater enhancements in the core semiconductor materials to ensure high performance. GaN has superior properties than silicon such as high breakdown voltage and saturation velocity. The bandgap in GaN …
- 医療用ポータブル超音波装置の世界市場2015-2019About portable ultrasound Portable ultrasound devices are medical imaging devices that utilize echo-enhanced ultrasound waves for diagnostic purposes. Portable ultrasound devices can be used at POC and can be operated on battery power. They are lighter and smaller than conventional ultrasound machines. Conventional ultrasound machines have certain limitations such as low diagnostic accuracy and di …
- IED（インテリジェント電子装置）の世界市場2015-2019About intelligent electronic device The intelligent electronic devices (IED) plays a significant role in automating substations and efficient monitoring of power delivery systems. IED is used in the power system to define devices that have electrical protection and monitoring functionalities with an advanced intelligent control system and can perform two-way communication with SCADA system. Moreov …
- 保護包装の世界市場2015-2019About protective packaging Protective packaging involves packaging solutions that provide protection and help in preserving consumer and industrial products, equipment, and machineries from any damaging effects during shipping and storage. Vendors in the market provide innovative protective packaging solutions to industries such as automotive, consumer electronics, appliances, pharmaceutical, and …
- 単純ヘルペス感染症(Herpes Simplex Infections)：治療薬開発パイプライン動向（2015年上半期版）Herpes Simplex Infections - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Herpes Simplex Infections, complete with comparative analysis at various stages, therapeutics asse …
- 学習管理システム（LMS）の世界市場2015-2022According to Stratistics MRC, the global learning management system market is expected to grow from $4.27 billion in 2015 to $17.08 billion by 2022 at a CAGR of 21.9%. The factors that are favoring the market growth are growing adoption of digital learning, improved collaboration between trainers and learners. Additionally, learning management system provides flexible and continuous learning platf …
- 研究所情報学の世界市場分析：製品別（LIMS、ELN、科学的データ管理システム、クロマトグラフィーデータシステム、ECM）、送達モード別（オンプレミス、Webホスト、クラウドベース）、コンポーネント別、エンドユーザー別、セグメント予測、2014-2025The global laboratory informatics market was valued at USD 2.15 billion in 2015 and is expected to reach a value of USD 3.83 billion by 2025. Increasing requirement for life sciences companies to comply with regulatory demands has further promoted the incorporation of laboratory information management systems (LIMS) as it helps professionals understand and fulfill the complex regulatory obligation …
- 米国の原子力産業分析：Analyzing the Nuclear Power Industry in the USThe United States is the world's largest supplier of commercial nuclear power. In recent years, there has been a renewed interest in nuclear power in the US. This has been facilitated in part by the federal government with the Nuclear Power 2010 Program, which coordinates efforts for building new nuclear power plants, and the Energy Policy Act which makes provisions for nuclear and oil industries. …
- 世界の銀行業界におけるIT支出市場動向（2012-2016）TechNavio's analysts forecast the Global Banking IT Spending market to grow at a CAGR of 3.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for risk management systems. The Global Banking IT Spending market has also been witnessing the increasing use of social media as a marketing tool. However, cyber security issues could pos …
- 浮腫：治療薬のグローバル治験動向（2014年下半期）Edema Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Edema Global Clinical Trials Review, H2, 2014" provides data on the Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Edema. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across …
